The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations.
Finding top talent in the hyper-competitive life science industries gets harder each day. With over 1,500 resources worldwide, 85 of whom are former FDA, we meet your precise resourcing needs through a fast, convenient talent selection process supported by a Total Quality Guarantee.
Get direct access to the specialized life science talent you need to bring products to market and keep them there. Whether you’re looking for consulting or project support, full-time contract, contract-to-hire, or direct-hire talent, we rapidly identify the right resource, the first time.
Build or augment your Quality Assurance team with top talent or outsource projects to an expert third party. We help thousands of life science companies find specialized resources and drive their projects to completion on-time and on-budget.
Develop and submit applications alongside former FDA and industry experts or fill in-house roles with select talent.
Maximize cost-effectiveness, flexibility, and scalability when building a partial or full in-house clinical operations team through rapid, reliable access to experienced clinical experts.
We are that partner. We help thousands of firms, including 17 of the top 25 global pharmaceutical, biotech, and medical device companies, find the resources they need, when and where they need them, through the optimal workforce model.
Our resources are located in several dozen countries and have expertise throughout the life sciences.
Our services are backed by a Total Quality Guarantee. If for any reason, you are dissatisfied with any service, we will provide you with a full refund.
The FDA is under intense pressure to ramp up inspections and enforcement activity. Are you prepared? Watch this special free two-hour event and learn how to detect and prevent the drug and device cGMP issues cited most frequently over the past four years.